• Enterprise value to EBIT forward of Clene Inc – FWB:84C0 TradingView Thu, 09 Jul 2026 22:59:01 GMT
• CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment Stocktwits Tue, 07 Jul 2026 13:20:46 GMT
• Clene Inc. (CLNN) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Shares - Strong Earnings Momentum dars.gov.et Thu, 02 Jul 2026 07:00:00 GMT
• CLNN Q1 2026 Earnings: Narrowed Loss Surprises Analysts Amidst Operational Focus - Annual Financial Report dars.gov.et Wed, 01 Jul 2026 14:37:28 GMT
• Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:43:21 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment Stocktwits Mon, 29 Jun 2026 05:21:41 GMT
• clene inc.(nasdaqcm: clnn) added to russell 3000e value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment Stocktwits Sat, 27 Jun 2026 19:34:26 GMT
• enterprise value to ebitda forward of clene inc. – nasdaq:clnn TradingView Fri, 26 Jun 2026 13:37:42 GMT
• enterprise value to ebitda forward of clene inc. – boats:clnn TradingView Thu, 25 Jun 2026 19:24:26 GMT
• enterprise value to ebit forward of clene inc. – boats:clnn TradingView Thu, 25 Jun 2026 17:29:42 GMT
• enterprise value to revenue forward of clene inc. – boats:clnn TradingView Thu, 25 Jun 2026 16:09:45 GMT
• clene inc. (clnn) financial health: profitability & balance sheet analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment Stocktwits Wed, 24 Jun 2026 07:11:27 GMT
• Clene Inc. (CLNN) Holds Near Support as Consolidation Persists Amid Minor Decline - Liquidity Order Flow dars.gov.et Wed, 24 Jun 2026 07:00:00 GMT
• clene inc. (clnn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• CLNN Q1 2026 Earnings: Clinical-Stage Biotech Delivers Narrower-Than-Expected Loss Despite No Revenue dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• clene inc. (clnn) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• clene inc. (clnn) risk assessment: volatility, financial risk & investment risk TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Clene Inc. (CLNNW) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Thu, 18 Jun 2026 22:36:25 GMT
• clene inc. (clnnw) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 21:50:25 GMT
• clene inc. (clnnw) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 20:45:59 GMT
• clene inc. (clnnw) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 20:36:42 GMT
• clene inc. (clnnw) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 20:11:35 GMT
• clene inc. (clnn) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 19:16:36 GMT
• clene inc. (clnn) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 17:55:28 GMT
• are medical stocks lagging c4 therapeutics (cccc) this year? Yahoo Finance Thu, 18 Jun 2026 13:40:04 GMT
• clene inc. (clnn) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 12:48:34 GMT
• clene inc. (clnn) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 09:16:34 GMT
• Clene Inc. (CLNNW) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 08:52:33 GMT
• clene inc. (clnn) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 01:05:25 GMT
• clene inc. (clnnw) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 20:36:32 GMT
• clene inc. (clnnw) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 19:55:20 GMT
• clene inc. (clnn) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 17:52:02 GMT
• clene inc. (clnn) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 17:52:01 GMT
• clene inc. (clnn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 17:19:19 GMT
• clene inc. (clnn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• clene inc. (clnn) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Clene (CLNN) grants CFO 15,000 stock options at $5.53 strike Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Clene (CLNN) Chief Science Officer receives 45,000-share stock option grant Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Clene (CLNN) CEO receives 65,000 stock options at $5.53 exercise price Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• clene q1 2026 earnings: eps surprise of 58.42% as biotech narrows losses - margin guidance newsline.com Wed, 10 Jun 2026 08:32:10 GMT
• TruckMountForums acquires Bane-Clene Corporation, uniting two fam The National Law Review Mon, 08 Jun 2026 07:20:54 GMT
• clene (clnn) may find a bottom soon, here's why you should buy the stock now MSN Sun, 07 Jun 2026 18:59:54 GMT
• clnn q1 2026 earnings: eps beats expectations amid no revenue, stock declines - one-time loss impact newsline.com Sun, 07 Jun 2026 14:37:30 GMT
• Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• clnn q1 2026 earnings: eps surprises to the upside as company focuses on clinical milestones - basic eps analysis dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• clnn q1 2026 earnings: significant eps beat but stock slides - fiscal year earnings newsline.com Tue, 02 Jun 2026 07:00:00 GMT
• CLNN Q1 2026 Earnings: Narrowed Loss Surprises Markets, Stock Slides Despite EPS Beat - Operating Margin Analysis dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• clnn q1 2026 earnings: eps beat despite minimal revenue; stock declines on pipeline uncertainties newsline.com Fri, 29 May 2026 07:00:00 GMT
• CLNN Q1 2026 Earnings: EPS Beat Driven by Cost Control Amid No Revenue - Debt Analysis Report dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• clnn q1 2026 earnings: narrower loss surprises analysts as company advances neurological pipeline - one-time loss impact newsline.com Mon, 25 May 2026 07:00:00 GMT
• clnn q1 2026 earnings: eps surges past estimates, but stock falls on absence of revenue - roa comparison newsline.com Mon, 25 May 2026 07:00:00 GMT
• clene inc. files form 8-k with sec detailing company information and common stock listing on nasdaq Minichart Sat, 23 May 2026 11:05:00 GMT
• clnn q1 2026 earnings: significant eps beat despite pre-revenue status and stock decline - core business growth newsline.com Sat, 23 May 2026 07:00:00 GMT
• clene extends note maturity and amends stock plan following annual meeting Investing.com Sat, 23 May 2026 00:21:13 GMT
• clene (nasdaq: clnn) extends convertible note maturity and adds 1m plan shares Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene (nasdaq: clnn) director granted 3,564 stock options at $6.81 exercise price Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene extends 2025 convertible notes to 2027, defers $150,000 monthly payments TradingView Fri, 22 May 2026 07:00:00 GMT
• clene (clnn) awards director two stock option grants at $6.81 Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene (nasdaq: clnn) director jonathon gay receives 3,728 stock options at $6.81 Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene (nasdaq: clnn) director awarded 4,361 stock options at $6.81 strike Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene inc. (clnn) director granted 5,159 stock options as equity compensation Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene extends note maturity and amends stock plan following annual meeting Investing.com Fri, 22 May 2026 07:00:00 GMT
• clene inc. (nasdaq: clnn) director receives 3,658 stock options at $6.81 strike Stock Titan Fri, 22 May 2026 07:00:00 GMT
• clene (clnn) director granted 4,291-share stock option package Stock Titan Fri, 22 May 2026 07:00:00 GMT
• 3 parkinson's biotech stocks analysts think are wildly mispriced Moomoo Fri, 22 May 2026 01:52:58 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment MSN Thu, 21 May 2026 15:00:31 GMT
• 3 parkinson's biotech stocks analysts think are wildly mispriced Sahm Thu, 21 May 2026 07:00:00 GMT
• are medical stocks lagging brightspring health services, inc. (btsg) this year? Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• clnn stock falls after roth labels accelerated approval for als drug a 'long shot' MSN Mon, 18 May 2026 21:30:05 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment MSN Sat, 16 May 2026 03:58:09 GMT
• is clene (clnn) overvalued after q1 2026? eps -$0.69 misses est. GuruFocus Fri, 15 May 2026 22:44:12 GMT
• jonestrading maintains clene(clnn.us) with buy rating, maintains target price $30 Moomoo Fri, 15 May 2026 21:58:55 GMT
• a quick look at today's ratings for clene(clnn.us), with a forecast between $30 to $50 Moomoo Fri, 15 May 2026 21:17:27 GMT
• Maxim Group Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $20 Moomoo Fri, 15 May 2026 07:00:00 GMT
• clnn stock falls after roth labels accelerated approval for als drug a ‘long shot’ Stocktwits Fri, 15 May 2026 07:00:00 GMT
• clene inc. 2026 q1 financial results, risk factors, and forward-looking statements – quarterly report highlights Minichart Fri, 15 May 2026 07:00:00 GMT
• chidozie ugwumba reports 9.7% stake in clene inc. (clnn) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• clene (clnn) receives positive analyst rating and funding outloo GuruFocus Fri, 15 May 2026 05:28:30 GMT
• roth mkm maintains clene(clnn.us) with buy rating, maintains target price $30 Moomoo Fri, 15 May 2026 04:56:04 GMT
• h.c. wainwright maintains clene(clnn.us) with buy rating, maintains target price $31 Moomoo Fri, 15 May 2026 04:38:27 GMT
• clene inc. (nasdaq: clnn) insider reports 1.83m shares, 13% Stock Titan Fri, 15 May 2026 01:10:53 GMT
• roth says fda approving clene’s als treatment nda a ‘long shot’ TipRanks Thu, 14 May 2026 21:31:38 GMT
• clene reports q1 2026 loss amid positive regulatory news for cnm-au8 GuruFocus Thu, 14 May 2026 21:22:30 GMT
• clene (clnn) receives positive analyst rating and funding outloo GuruFocus Thu, 14 May 2026 21:14:12 GMT
• clene inc. 2026 q1 financial results, risk factors, and forward-looking statements – quarterly report highlights Minichart Thu, 14 May 2026 19:55:00 GMT
• clene inc - enters second amendment to senior secured convertible notes - sec filing TradingView Thu, 14 May 2026 12:18:22 GMT
• clene q1 loss widens on warrant liability issuance costs TradingView Thu, 14 May 2026 12:09:39 GMT
• clene inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 14 May 2026 11:55:00 GMT
• clene inc. (clnn) posts larger q1 2026 loss and flags going concern Stock Titan Thu, 14 May 2026 11:54:42 GMT
• Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• Experimental ALS drug moves toward FDA filing as Clene shores up cash Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights Investing News Network Thu, 14 May 2026 07:00:00 GMT
• CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’ Stocktwits Thu, 14 May 2026 07:00:00 GMT
• clene inc. (nasdaq: clnn) insider reports 1.83m shares, 13% Stock Titan Thu, 14 May 2026 07:00:00 GMT
• clene (clnn) reports q1 revenue and progress on als treatment GuruFocus Thu, 14 May 2026 07:00:00 GMT
• clene inc. reports q1 2026 financial results and advances cnm-au8 for als fda approval Minichart Thu, 14 May 2026 07:00:00 GMT
• chidozie ugwumba reports 1.92m clene shares (nasdaq: clnn) 14.8% Stock Titan Thu, 14 May 2026 07:00:00 GMT
• clene (nasdaq: clnn) readies als nda as q1 loss deepens and cash runway extends Stock Titan Thu, 14 May 2026 07:00:00 GMT
• ugwumba chidozie sells $604,129 in clene inc. stock by investing.com Investing.com Australia Thu, 14 May 2026 07:00:00 GMT
• clene expects to submit nda for cnm-au8 under the accelerated approval pathway in 3q >clnn Moomoo Thu, 14 May 2026 07:00:00 GMT
• clene insider sold shares worth $604,130, according to a recent sec filing marketscreener.com Thu, 14 May 2026 07:00:00 GMT
• major clene insider makes a big move with eye-catching stock sale TipRanks Thu, 14 May 2026 06:45:08 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment MSN Thu, 14 May 2026 03:33:32 GMT
• clene inc. (clnn) stock price | live quotes & charts | nasdaq StocksToTrade Thu, 14 May 2026 00:27:00 GMT
• major clene (clnn) holder symbiosis ii, llc sells 95,473 shares, keeps stake Stock Titan Wed, 13 May 2026 07:00:00 GMT
• vivo opportunity (clnn) reports near‑9.99% holdings including warrants Stock Titan Wed, 13 May 2026 02:15:42 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment MSN Tue, 12 May 2026 12:53:58 GMT
• vivo opportunity (clnn) reports near‑9.99% holdings including warrants Stock Titan Tue, 12 May 2026 07:00:00 GMT
• clene stock jumps after fda opens door to accelerated approval for als drug MSN Mon, 11 May 2026 20:11:27 GMT
• clene nanomedicine aims to be the ‘gold standard’ in neurodegenerative disease biobuzz.io Mon, 11 May 2026 20:05:28 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment MSN Mon, 11 May 2026 17:45:26 GMT
• symbiosis ii llc sells clnn shares (clnn) across multiple open-market trades Stock Titan Mon, 11 May 2026 07:00:00 GMT
• clnn stock rises 8% – here’s what the fda update means for clene’s als treatment MSN Sun, 10 May 2026 23:52:31 GMT
• ccorf maintains clene(clnn.us) with buy rating, raises target price to $50 富途牛牛 Sun, 10 May 2026 21:38:15 GMT
• clene moves toward accelerated approval nda filing for cnm-au8 in als Neurology Live Sun, 10 May 2026 10:00:00 GMT
Clene Inc(NASDAQ:CLNN) 
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. ...
Share this website to your friends